{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:16:13Z","timestamp":1778760973825,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44617-y","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T07:15:21Z","timestamp":1774336521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel explainable deep learning based drug sensitivity prediction for early treatment of breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"A.","family":"Anushya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awatef","family":"Alreshidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nallala Hima","family":"Varshini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Venkatachalam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seohyun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaehyuk","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"44617_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106936","volume":"107","author":"Y Zou","year":"2022","unstructured":"Zou, Y. et al. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. Int. J. Surg. 107, 106936 (2022).","journal-title":"Int. J. Surg."},{"issue":"3","key":"44617_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102247","volume":"9","author":"M Bottosso","year":"2024","unstructured":"Bottosso, M. et al. Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancer. ESMO Open 9(3), 102247 (2024).","journal-title":"ESMO Open"},{"key":"44617_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106936","volume":"107","author":"Y Zou","year":"2022","unstructured":"Zou, Y. et al. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. Int. J. Surg. 107, 106936 (2022).","journal-title":"Int. J. Surg."},{"key":"44617_CR4","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1038\/s41467-022-33291-z","volume":"13","author":"S Chawla","year":"2022","unstructured":"Chawla, S. et al. Gene expression based inference of cancer drug sensitivity. Nat. Commun. 13, 5680. https:\/\/doi.org\/10.1038\/s41467-022-33291-z (2022).","journal-title":"Nat. Commun."},{"key":"44617_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.783450","volume":"9","author":"S Afzal","year":"2022","unstructured":"Afzal, S. et al. Breast cancer; discovery of novel diagnostic biomarkers, drug resistance, and therapeutic implications. Front. Mol. Biosci. 9, 783450 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"44617_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-021-07581-7","volume":"22","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Predicting tumour response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines. BMC Genomics 22, 272. https:\/\/doi.org\/10.1186\/s12864-021-07581-7 (2021).","journal-title":"BMC Genomics"},{"key":"44617_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.740720","volume":"11","author":"M Fiorillo","year":"2021","unstructured":"Fiorillo, M., \u00d3zsv\u00e1ri, B., Sotgia, F. & Lisanti, M. P. High ATP production fuels cancer drug resistance and metastasis: Implications for mitochondrial ATP depletion therapy. Front. Oncol. 11, 740720 (2021).","journal-title":"Front. Oncol."},{"key":"44617_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s12276-020-00510-w","volume":"53","author":"X Pan","year":"2021","unstructured":"Pan, X. et al. METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner. Exp. Mol. Med. 53, 91\u2013102. https:\/\/doi.org\/10.1038\/s12276-020-00510-w (2021).","journal-title":"Exp. Mol. Med."},{"key":"44617_CR9","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1007\/s11030-023-10780-x","volume":"28","author":"HP Manivannan","year":"2024","unstructured":"Manivannan, H. P., Veeraraghavan, V. P. & Francis, A. P. Identification of molecular targets of Trigonelline for treating breast cancer through network pharmacology and bioinformatics-based prediction. Mol. Divers. 28, 3835\u20133857. https:\/\/doi.org\/10.1007\/s11030-023-10780-x (2024).","journal-title":"Mol. Divers."},{"key":"44617_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-31153-2","volume":"13","author":"W Lv","year":"2023","unstructured":"Lv, W. et al. A novel immune score model predicting the prognosis and immunotherapy response of breast cancer. Sci. Rep. 13, 6403. https:\/\/doi.org\/10.1038\/s41598-023-31153-2 (2023).","journal-title":"Sci. Rep."},{"key":"44617_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.988680","volume":"12","author":"ZR Jiang","year":"2022","unstructured":"Jiang, Z. R. et al. Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients. Front. Oncol. 12, 988680 (2022).","journal-title":"Front. Oncol."},{"key":"44617_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108253","volume":"237","author":"JY So","year":"2022","unstructured":"So, J. Y., Ohm, J., Lipkowitz, S. & Yang, L. Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options. Pharmacol. Ther. 237, 108253 (2022).","journal-title":"Pharmacol. Ther."},{"key":"44617_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00496-y","volume":"8","author":"HYK Yip","year":"2024","unstructured":"Yip, H. Y. K. et al. Integrative modeling uncovers p21-driven drug resistance and prioritizes therapies for PIK3CA-mutant breast cancer. npj Precis. Oncol. 8, 20. https:\/\/doi.org\/10.1038\/s41698-024-00496-y (2024).","journal-title":"npj Precis. Oncol."},{"key":"44617_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10549-023-07170-0","volume":"204","author":"SMM Yahya","year":"2024","unstructured":"Yahya, S. M. M. et al. Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene. Breast Cancer Res. Treat. 204, 133\u2013149. https:\/\/doi.org\/10.1007\/s10549-023-07170-0 (2024).","journal-title":"Breast Cancer Res. Treat."},{"key":"44617_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.111608","volume":"127","author":"J Lu","year":"2025","unstructured":"Lu, J. et al. Unveiling the role of MDH1 in breast cancer drug resistance through single-cell sequencing and schottenol intervention. Cell. Signal. 127, 111608 (2025).","journal-title":"Cell. Signal."},{"issue":"2","key":"44617_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1109\/TCBB.2019.2919581","volume":"18","author":"M Li","year":"2021","unstructured":"Li, M. et al. DeepDSC: A deep learning method to predict drug sensitivity of cancer cell lines. IEEE\/ACM Trans. Comput. Biol. Bioinform. 18(2), 575\u2013582. https:\/\/doi.org\/10.1109\/TCBB.2019.2919581 (2021).","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"issue":"1","key":"44617_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.synbio.2024.09.003","volume":"10","author":"Q Wang","year":"2025","unstructured":"Wang, Q., Liu, X. & Yan, G. Predicting effective drug combinations for cancer treatment using a graph-based approach. Synth. Syst. Biotechnol. 10 (1), 148\u2013155 (2025).","journal-title":"Synth. Syst. Biotechnol."},{"key":"44617_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2025.110339","author":"G Pan","year":"2025","unstructured":"Pan, G. et al. Integration of MRI radiomics and clinical data for preoperative prediction of vascular invasion in breast cancer: A deep learning approach. Magn. Reson. Imaging https:\/\/doi.org\/10.1016\/j.mri.2025.110339 (2025).","journal-title":"Magn. Reson. Imaging"},{"key":"44617_CR19","doi-asserted-by":"publisher","unstructured":"Yi Hoong, J. T. et al. Evaluation of Machine Learning Techniques for Prediction of Breast Cancer,., 21st IEEE International Colloquium on Signal Processing & Its Applications (CSPA), Pulau Pinang, Malaysia, 2025, pp. 349\u2013354, (2025). https:\/\/doi.org\/10.1109\/CSPA64953.2025.10933121","DOI":"10.1109\/CSPA64953.2025.10933121"},{"key":"44617_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-87622-3","volume":"15","author":"SM Noman","year":"2025","unstructured":"Noman, S. M. et al. Leveraging survival analysis and machine learning for accurate prediction of breast cancer recurrence and metastasis. Sci. Rep. 15, 3728. https:\/\/doi.org\/10.1038\/s41598-025-87622-3 (2025).","journal-title":"Sci. Rep."},{"key":"44617_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-025-01960-8","volume":"27","author":"L H\u00e4berle","year":"2025","unstructured":"H\u00e4berle, L. et al. Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers. Breast Cancer Res. 27, 13. https:\/\/doi.org\/10.1186\/s13058-025-01960-8 (2025).","journal-title":"Breast Cancer Res."},{"key":"44617_CR22","doi-asserted-by":"publisher","first-page":"29327","DOI":"10.1109\/ACCESS.2025.3541051","volume":"13","author":"D Youssef","year":"2025","unstructured":"Youssef, D., Atef, H., Gamal, S., El-Azab, J. & Ismail, T. Early breast cancer prediction using thermal images and hybrid feature extraction-based system. IEEE Access 13, 29327\u201329339. https:\/\/doi.org\/10.1109\/ACCESS.2025.3541051 (2025).","journal-title":"IEEE Access"},{"key":"44617_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107746","volume":"168","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. XGraphCDS: An explainable deep learning model for predicting drug sensitivity from gene pathways and chemical structures. Comput. Biol. Med. 168, 107746 (2024).","journal-title":"Comput. Biol. Med."},{"key":"44617_CR24","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1021\/acs.jcim.1c00706","volume":"61","author":"I Jin","year":"2021","unstructured":"Jin, I. & Nam, H. HiDRA: Hierarchical network for drug response prediction with attention. J. Chem. Inf. Model. 61, 3858\u20133867. https:\/\/doi.org\/10.1021\/acs.jcim.1c00706 (2021).","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"44617_CR25","doi-asserted-by":"publisher","first-page":"e1012012","DOI":"10.1371\/journal.pcbi.1012012","volume":"20","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. DBDNMF: A dual branch deep neural matrix factorization method for drug response prediction. PLoS Comput. Biol. 20(4), e1012012 (2024).","journal-title":"PLoS Comput. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44617-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44617-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44617-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:02:24Z","timestamp":1778760144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44617-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44617"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44617-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"14833"}}